Cargando…

Shifting the optimal stiffness for cell migration

Cell migration, which is central to many biological processes including wound healing and cancer progression, is sensitive to environmental stiffness, and many cell types exhibit a stiffness optimum, at which migration is maximal. Here we present a cell migration simulator that predicts a stiffness...

Descripción completa

Detalles Bibliográficos
Autores principales: Bangasser, Benjamin L., Shamsan, Ghaidan A., Chan, Clarence E., Opoku, Kwaku N., Tüzel, Erkan, Schlichtmann, Benjamin W., Kasim, Jesse A., Fuller, Benjamin J., McCullough, Brannon R., Rosenfeld, Steven S., Odde, David J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5458120/
https://www.ncbi.nlm.nih.gov/pubmed/28530245
http://dx.doi.org/10.1038/ncomms15313
Descripción
Sumario:Cell migration, which is central to many biological processes including wound healing and cancer progression, is sensitive to environmental stiffness, and many cell types exhibit a stiffness optimum, at which migration is maximal. Here we present a cell migration simulator that predicts a stiffness optimum that can be shifted by altering the number of active molecular motors and clutches. This prediction is verified experimentally by comparing cell traction and F-actin retrograde flow for two cell types with differing amounts of active motors and clutches: embryonic chick forebrain neurons (ECFNs; optimum ∼1 kPa) and U251 glioma cells (optimum ∼100 kPa). In addition, the model predicts, and experiments confirm, that the stiffness optimum of U251 glioma cell migration, morphology and F-actin retrograde flow rate can be shifted to lower stiffness by simultaneous drug inhibition of myosin II motors and integrin-mediated adhesions.